Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen Franklin Insider Profile
4 Followers
Stephen Franklin, Chief Executive at Evgen Pharma, holds 1.38M shares in Evgen Pharma (Ticker: GB:TCF). Most recently, Stephen Franklin Bought 56,000p shares of Evgen Pharma on Jan 19, 2016 for an estimated value of 12.46K.
Stephen Franklin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Stephen Franklin's holdings
Insider Roles
Chief Executive
Roles that Stephen Franklin holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Stephen Franklin
Stephen Franklin's Trading History
List of latest transactions for each holding click on a transaction to see Stephen Franklin's performance on stock
You May Also Like
Stephen Franklin insider profile FAQ
What is the percentage of profitable transactions made by Stephen Franklin?
The percentage of profitable transactions made by Stephen Franklin is ―.
What is the average return per transaction made by Stephen Franklin?
The average return per transaction made by Stephen Franklin is ―.
What stocks does Stephen Franklin hold?
Stephen Franklin holds: GB:TCF stocks.
What was Stephen Franklin’s latest transaction?
Stephen Franklin latest transaction was an Informative Buy of 12.46K.
What was Stephen Franklin's most profitable transaction?
Stephen Franklin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Stephen Franklin's role in Evgen Pharma?
Stephen Franklin's role in Evgen Pharma is Chief Executive.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.